Plum Bio plans to buy Ningxia Yipin, the company continues to suspend trading

Meihua Biotech Group Co., Ltd("Company", "Listed Company") was suspended from trading on August 26, 2014 due to the planning of the issuance of shares to purchase assetsSubsequently, the company issued a number of "major matters continue to suspend the notice." Due to the large number of underlying shareholders, some shareholders are required to perform the necessary internal approval procedures, and the parties to the transaction on the transaction subject performance commitments, payment methods, transaction plans and other aspects of further consultation, September 30, 2014 and October 30, 2014, respectively, the Company issued "on the planning of the issuance of shares to purchase assets and extended re-listing of the announcement" (announcement number: 2014-049, 2014-056)E4G
The Company intends to acquire the shares of Ningxia Yipin Biotech Co., Ltdthrough the issuance of shares and cash payment, and to raise supporting funds from no more than 10 specific investors in the non-public issuance of sharesThe total amount of funds raised shall not exceed 25% of the total transaction amount, and the funds raised shall be used to pay the cash consideration of the assets under lying and the construction and working capital arrangements for the underlying assets, and shall not be used to supplement the working capital of the listed companyE4G
During the suspension period, the Company engaged independent financial advisers, legal advisers, auditanding and asset assessment intermediaries to conduct due diligence, audit, evaluation and other work on asset purchasesDue to the uncertainty of this matter, the company's shares will continue to be suspended for the purpose of fair information disclosure and the protection of the interests of investorsE4GMeihua Biotech Group Co., Ltd("The Company", "Listed Company") was suspended from trading on August 26, 2014 due to the planning of the issuance of shares to purchase assetsSubsequently, the company issued a number of "major matters continue to suspend the notice." Due to the large number of underlying shareholders, some shareholders are required to perform the necessary internal approval procedures, and the parties to the transaction on the transaction subject performance commitments, payment methods, transaction plans and other aspects of further consultation, September 30, 2014 and October 30, 2014, respectively, the Company issued "on the planning of the issuance of shares to purchase assets and extended re-listing of the announcement" (announcement number: 2014-049, 2014-056)E4G
　　The Company intends to acquire the shares of Ningxia Yipin Biotech Co., Ltd through the issuance of shares and cash payment, and to raise supporting funds from no more than 10 specific investors in the non-public issuance of shares The total amount of funds raised shall not exceed 25% of the total transaction amount, and the funds raised shall be used to pay the cash consideration of the assets under lying and the construction and working capital arrangements for the underlying assets, and shall not be used to supplement the working capital of the listed company E4G
　　During the suspension period, the Company engaged independent financial advisers, legal advisers, auditanding and asset assessment intermediaries to conduct due diligence, audit, evaluation and other work on asset purchases Due to the uncertainty of this matter, the company's shares will continue to be suspended for the purpose of fair information disclosure and the protection of the interests of investors E4G
Share it on feed